GR862633B - Substituted benzoate ester prodrugs of estrogens - Google Patents

Substituted benzoate ester prodrugs of estrogens

Info

Publication number
GR862633B
GR862633B GR862633A GR860102633A GR862633B GR 862633 B GR862633 B GR 862633B GR 862633 A GR862633 A GR 862633A GR 860102633 A GR860102633 A GR 860102633A GR 862633 B GR862633 B GR 862633B
Authority
GR
Greece
Prior art keywords
estrogens
ester prodrugs
benzoate ester
substituted benzoate
substituted
Prior art date
Application number
GR862633A
Other languages
English (en)
Inventor
Aungst Bruce Jeffrey
Hussain Munir Alwan
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of GR862633B publication Critical patent/GR862633B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR862633A 1985-11-01 1986-10-30 Substituted benzoate ester prodrugs of estrogens GR862633B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/793,892 US4757062A (en) 1985-11-01 1985-11-01 Substituted benzoate ester prodrugs of estrogens

Publications (1)

Publication Number Publication Date
GR862633B true GR862633B (en) 1987-03-03

Family

ID=25161090

Family Applications (1)

Application Number Title Priority Date Filing Date
GR862633A GR862633B (en) 1985-11-01 1986-10-30 Substituted benzoate ester prodrugs of estrogens

Country Status (12)

Country Link
US (1) US4757062A (el)
EP (1) EP0221506B1 (el)
JP (1) JPS62120398A (el)
AT (1) ATE49216T1 (el)
AU (1) AU583160B2 (el)
CA (1) CA1255295A (el)
DE (1) DE3667982D1 (el)
DK (1) DK521786A (el)
ES (1) ES2002058A6 (el)
GR (1) GR862633B (el)
IL (1) IL79710A0 (el)
ZA (1) ZA868272B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6702705B1 (en) 1988-05-04 2004-03-09 Igen International, Inc. Prodrugs activated by targeted catalytic proteins
DK24089D0 (da) * 1989-01-20 1989-01-20 Hans Bundgaard Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups
US4909563A (en) * 1989-04-12 1990-03-20 Phillip E. Walker Automatically deployable covering device
US6258360B1 (en) * 1989-05-04 2001-07-10 Igen International, Inc. Prodrugs activated by targeted catalytic proteins
JPH06510529A (ja) * 1991-08-05 1994-11-24 イゲン，インコーポレーテッド 目標とする触媒性たんぱく質により活性化されるプロドラッグ
JP4481660B2 (ja) * 2002-04-02 2010-06-16 中外製薬株式会社 エストロン誘導体およびその製造方法
JP6704535B2 (ja) * 2017-01-25 2020-06-03 中山大学中山眼科中心 ラノステロールプロドラッグ化合物、その製造方法及び応用
SG11202100665WA (en) * 2018-07-25 2021-02-25 Guangzhou Ocusun Ophthalmic Biotechnology Co Ltd Crystal form of lanosterol prodrug compound and application thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD83130A (el) *
US2054271A (en) * 1932-05-17 1936-09-15 Schering Kahlbaum Ag Production of crystallized hormone esters
US2243887A (en) * 1935-11-09 1941-06-03 Schering Corp Tertiary carbinols of the cyclopentano-polyhydrophenanthrene series and a method of producing the same
US2251939A (en) * 1935-11-22 1941-08-12 Schering Corp Tertiary alcohols of the cyclopentano polyhydro phenanthrene series and a method of producing the same
CH202847A (de) * 1937-06-26 1939-02-15 Chem Ind Basel Verfahren zur Darstellung von Acetylen-Derivaten der Cyclopentanopolyhydrophenanthren-Reihe.
US2265976A (en) * 1937-10-25 1941-12-09 Schering Corp Tertiary alcohols of the estrane series and their derivatives and a process for their manufacture
US3347880A (en) * 1962-10-05 1967-10-17 Schering Corp 17alpha-halogenoethinylestranes
GB1039447A (en) * 1964-02-21 1966-08-17 Nicholas Gueritee Oestradiol derivatives
US3624113A (en) * 1968-12-11 1971-11-30 Warner Lambert Co Long-acting estradiol derivatives
US3634404A (en) * 1969-05-08 1972-01-11 American Home Prod 7alpha 8alpha-methyleneestrogens and preparation thereof
US3647784A (en) * 1970-02-02 1972-03-07 American Home Prod Preparation of steroidal formate esters
US4110324A (en) * 1974-02-26 1978-08-29 Nicolas Gueritee Nicotinic derivatives of estriol
DE2506548C2 (de) * 1975-02-17 1986-05-15 Theramex S.A., Paris Östriol-Nicotinsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CA1076480A (en) * 1975-04-28 1980-04-29 John S. Kent Inert core implant pellet
FR2401173A1 (fr) * 1977-06-27 1979-03-23 Roussel Uclaf Nouveaux steroides, leur procede de preparation et leur application dans la synthese de steroides marques au tritium
DE2818164A1 (de) * 1978-04-21 1979-10-31 Schering Ag 1,3-dibenzoesaeureester des 17alpha- ethinyl-7 alpha -methyl-1,3,5(10)-oestratrien- 1,3,17 beta -triols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
US4318908A (en) * 1979-12-06 1982-03-09 Kureha Kagaku Kogyo Kabushiki Kaisha Methylated prostaglandin derivatives
DE3144049A1 (de) * 1981-11-03 1983-05-19 Schering Ag, 1000 Berlin Und 4619 Bergkamen 16(beta)-methyl-8(alpha)-oestradiole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
FI83087C (fi) * 1984-05-16 1991-05-27 Schering Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara estriol-3,17-diestrar.

Also Published As

Publication number Publication date
ZA868272B (en) 1988-07-27
DE3667982D1 (de) 1990-02-08
JPS62120398A (ja) 1987-06-01
DK521786A (da) 1987-05-02
EP0221506A1 (en) 1987-05-13
ATE49216T1 (de) 1990-01-15
AU6461686A (en) 1987-05-07
US4757062A (en) 1988-07-12
EP0221506B1 (en) 1990-01-03
DK521786D0 (da) 1986-10-31
IL79710A0 (en) 1986-11-30
ES2002058A6 (es) 1988-07-01
AU583160B2 (en) 1989-04-20
CA1255295A (en) 1989-06-06

Similar Documents

Publication Publication Date Title
ZA877420B (en) Transdermal administration of progesterone,estradiol esters,and mixtures thereof
AU8298287A (en) Transdermal contraceptive formulations
NZ212641A (en) 3-benzoate esters of morphinan derivatives, intermediates and analgesic compositions
GEP19981274B (en) Urinary follicle stimulating hormone, pharmaceutical composition, component of pharmaceutical composition
AU591705B2 (en) Emulsion compositions for the parenteral and/or oral administration of sparingly water soluble ionizable hydrophobic drugs
HU9400495D0 (en) Peptides having growth hormone releasing activity
IL92496A0 (en) Compositions for transdermal delivery of estradiol
AU1025988A (en) Pharmaceutical composition of follicle stimulating hormone and luteinizing hormone
GR862633B (en) Substituted benzoate ester prodrugs of estrogens
NZ215587A (en) 3-oxoandrost-4-ene-17beta-carboxylic acid ester derivatives and pharmaceutical compositions
AU571980B2 (en) Self-adhesive plaster for transdermal administration
AU1554076A (en) Pharmaceutical Compositions and Compounds
IL53693A (en) Pharmaceutical compositions comprising anti-inflammatory drugs and certain chromone compounds
AU2617288A (en) Pharmaceutical formulations for transdermal administration
AU6217186A (en) Pharmaceutical composition of desferrioxamine b or desferriferrithiocine for malaria treatment
NZ226371A (en) Phenyl carboxylic acid ether derivatives and pharmaceutical compositions
JPS6416790A (en) 6-substituted peneem ester as anti-inflammatory drug and anti-modifying agent
NZ188101A (en) N-substituted-2-aminobenzoic acid derivatives and pharmaceutical compositions
FR2511866B1 (fr) Formulations pharmaceutiques de pro-insuline humaine
IL57760A (en) Pharmaceutical compositions comprising trimethoprim and n-ethyl-gamma-pyridone-3-carboxylic acid derivatives
DE3665061D1 (en) Anthranilic acid ester derivatives and anti-inflammatory and analgesic external preparations containing the same
NZ181467A (en) Tetrahydronaphthalene derivatives and pharmaceutical compositions
AU2347188A (en) Preparation method of alpha-l-aspartyl-l-phenylalanine methyl ester having improved solubilization
GB2246954B (en) Pharmaceutical compositions comprising metrondiazole and an anti-inflammatory steroid
NZ186786A (en) Furoyl-and thenoylaryloxyalkyl carboxylic acid derivatives and pharmaceutical compositions